Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical profile of SU-11248 and PK/PD data published

Feb. 5, 2003

2C3 antibody inhibits tumor growth by 75%

Feb. 5, 2003

New phase I trial for VNP-40101M in solid tumors

Feb. 5, 2003

Pyrimidine-based tyrosine kinase inhibitors covered by Merck patent

Feb. 5, 2003

Arizona State U. researchers design new combretastatin A3 prodrugs

Feb. 5, 2003

Cytovia scientists design caspase activators and apoptosis inducers

Feb. 5, 2003

Enrollment completed in phase III Tarceva trial in refractory NSCLC

Feb. 4, 2003

Idec and Biogen to codevelop three Biogen oncology therapeutics

Feb. 4, 2003

New antitumor daunorubicin derivatives designed by Pharmacia

Feb. 4, 2003

Corixa and GSK form cancer vaccine collaboration

Feb. 3, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...